10
A. Khutia et al. / Inorganica Chimica Acta xxx (2014) xxx–xxx
coordination sphere of one of the four Pt ions, can be considered an
intermediate between the structures seen in 5, 6, 8 (with all-ht
binding modes through N3 and O4) and the putative M4L2 ana-
logue of 4 with mixed O2,O4 binding of two of the four metals. It
is obvious, that with a larger excess of M, even products of M5L2
as well as M6L2 stoichiometries are feasible.
With the exception of 7, all structurally characterized com-
plexes have the bridging ligands 10 in transoid orientations. As
briefly pointed out above (Section 2.3.) there is no compelling rea-
son why the bis(1-methyluracil-5-yl)methane ligand in its depro-
tonated form (10) should not be able to also adopt a cisoid
arrangement and to form cone calixarene structures. If realized,
yet additional linkage isomers of M4L2 stoichiometry would be
possible, and in addition species of composition M3L2, M5L2, and
M6L2. In the latter case, all eight exocyclic oxygen atoms of the four
uracil rings would be occupied by metal ions, and in addition all
four N3 sites.
obtained was dissolved in 40 mL dichloromethane. The bis(pyra-
zol-1-yl)propane (282 mg, 1.60 mmol) was added and the resulting
solution was stirred at room temperature for 12 h. The yellow solid
was filtered off, washed with CH2Cl2 and dried at 40 °C. Yield:
500 mg (88%). Anal. Calc. for C9H12N4Cl2Pd: C, 30.6; H, 3.4; N,
15.9. Found: C, 30.4; H, 3.5; N, 16.8%. 1H NMR (CDCl3, 200 MHz,
d/ppm): 8.32 (H3, d, 3J = 3.0 Hz), 7.74 (H5, d, 3J = 3.0 Hz), 6.46
(H4, t, 3J = 3.0 Hz), 2.78 (CH3, s).
4.3. Second polymorph of bis(1-methyluracil-5-yl)methane
monohydrate (1a)
AgNO3 (85 mg, 0.5 mmol) was added to a solution of 1 (52.8 mg,
0.2 mmol) in a 1:1-mixture of MeOH and water (2 mL), the mixture
stirred for 2 h, and then left in a refrigerator at 4 °C for crystalliza-
tion. Two days later, colorless crystals of 1a were collected (30 mg,
57%). X-ray crystallography showed the crystals not to be a Ag
complex of 1 but rather to be a second polymorph of the previously
studied 1 [15].
3. Summary
4.4. Bis(1-methyluracil-5-yl)methyl-benzene (2)
In this manuscript we describe a series of metal complexes de-
rived from cis-a2MII and bis(1-metyluracil-5-yl)methane ligands.
With a single exception (complex 7) all compounds are metallacy-
cles, hence can be termed metallacalix[n]arenes. It strikes that all
compounds except 3 contain stacked dimetal units. This feature
is attributed to the pronounced basicity of the exocyclic oxygen
atoms of uracil anions, as numerously demonstrated by us, and
has some precedence in cyclic complexes of uracil and cytosine
[3,5] as well as larger imidato ligands [32] or the cyanurato ligand
with its three imide functionalities [33]. The complexity of the here
discussed metallacalix[4]arenes is, among others, evident from the
fact that species of M4L2 stoichiometry, for example, can conceiv-
ably exist in numerous isomeric variants, and that all species hav-
ing head–tail disposed dimetal entities are inherently chiral.
Structurally related cages (e.g., triangle [34], square [35], octahe-
dron [36]) have also been synthesized by applying dimetal units
with metal–metal bonds and tetradentate bridging ligands such
as amidinates, oxalate, and dicarboxylates, but in these complexes
the dimetal units do not represent stereogenic elements. In related
work we have uncovered that metallacalix[4]arenes derived from
the parent nucleobases uracil and cytosine can occur in a large
number of isomeric forms [35], and have proposed that this feature
may be one reason to account for the difficulty in fully character-
izing a class of potent antitumor agents called ‘‘platinum pyrimi-
dine blues’’ [37]. It appears that the here described bis(1-
methyluracil-5-yl)methane ligand is similar as far as the complex-
ity in terms of metal coordination by cis-a2PtII is concerned.
This compound was synthesized in 90% yield according to a
slightly modified version from that reported in the literature
[15,17]. Specifically, 1-methyluracil was reacted with benzalde-
hyde in conc. HCl. 1H NMR (DMSO-d6, 298 K, d, ppm): 11.32 (2H,
s, N3–H), 7.03 (2H, s, C6–H), 5.09 (1H, s, CHPh), 3.19 (6H, s, CH3),
7.17 (2H, d, Ph), 7.24 (1H, dd, Ph), 7.32 (2H, dd, Ph).
4.5. [Pd(bipzp)(10)]2. in [Pd(bipzp)(10)]2ꢀ13H2O (3)
A
mixture of PdCl2(bipzp) (353 mg, 1 mmol) and AgNO3
(340 mg, 2 mmol) was stirred in water (50 mL) at 60 °C for 2.5 h
in dark. The suspension obtained was cooled to 0 °C and the precip-
itated AgCl was subsequently removed by filtration. To the filtrate
thus obtained, 1 (264 mg, 1 mmol) was added and pH of the solu-
tion adjusted to ca 9.0 by addition of aqueous 1 M NaOH solution.
The reaction mixture was stirred overnight at 60 °C. The resulting
solution was concentrated to 5 mL, centrifuged and left in a beaker
at 4 °C. Prism shaped, light yellow crystals were obtained after two
days (150.6 mg, 12%). Anal. Calc. for C40H62N16O17Pd2 (9-hydrate):
C, 38.4; H, 5.0; N, 17.9. Found: C, 38.4; H, 5.1; N, 18.0%. 1H NMR
3
(D2O, pD 5.8, 298 K, d, ppm): 8.120 (4H, d, H30, JH–H = 2.5 Hz),
7.632 (4H, s, H50), 7.416 (4H, s, H6), 6.451 (4H, s, H40), 3.356
(12H, s, CH3), 3.076 (4H, s, CH2), and 2.991 (12H, s, CH03).
4.6. [{Pd(bipzp)(10-N3)}2(Ag–O2,O4)]n in [{Pd(bipzp)(10-N3)}2(Ag–
O2,O4)]nꢀ15H2O (4)
4. Experimental
To an aqueous solution (3 mL) of 3 (65 mg, 0.05 mmol), 0.5 mL
aqueous solution of AgNO3 (42.5 mg, 0.25 mmol) was added with
stirring. The formation of a colorless precipitate was observed.
The reaction mixture was cooled in an ice bath for 2 h and the pre-
cipitate formed in due course was subsequently collected by filtra-
tion. Recrystallization from water (4 mL) yielded colorless single
crystals (10.6 mg crystals, 10%). Anal. Calc. for C40H64N17O21Pd2Ag
(5-hydrate): C, 35.6; H, 4.0; N, 17.6. Found: C, 35.5; H, 3.9; N,
17.6%. The 1H NMR spectrum of 4 in D2O is virtually identical with
that of compound 3, as can be expected.
4.1. Starting materials and preparations
2,20-bipyridine (2,20-bpy), uracil, paraformaldehyde, benzalde-
hyde, HCl, K2PtCl4, K2PdCl4, PdCl2, and AgNO3 were of commercial
origin and used as received without further purification. 1-Methyl-
uracil [38], bis(pyrazol-1-yl)propane [39] bis(1-methyluracil-5-
yl)methane monohydrate (1) [15] PtCl2(2,20-bpy) [40], and
PdCl2(2,20-bpy) [41] were prepared as described in the literature.
4.2. Preparation of PdCl2(bipzp)
4.7. ht,ht-{[Pd(2,20-bpy)]2(10)}2(H3O)(NO3)5ꢀ8H2O (5)
This compound was prepared in a slightly modified version of
that reported in Ref. [20]. PdCl2 (285 mg, 1.60 mmol) was dissolved
in refluxing acetonitrile (15 mL) and then cooled to room temper-
ature. The solution was evaporated to dryness and the solid
Pd(2,20-bpy)Cl2 (67 mg, 0.2 mmol) was stirred with AgNO3
(68 mg, 0.4 mmol) in water (10 mL) with light excluded at 40 °C
for 12 h. The suspension obtained was cooled to 0 °C in ice bath
for 30 min. Then AgCl was removed from the solution by filtration.